{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:00:45Z","timestamp":1792839645387,"version":"4.5.0"},"reference-count":79,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2012,4,8]],"date-time":"2012-04-08T00:00:00Z","timestamp":1333843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2012,6]]},"abstract":"Summary<\/jats:title>\n \n Background<\/jats:title>\n Vasoactive medications such as vasopressin, somatostatin and their analogues (terlipressin, vapreotide and octreotide) are commonly used for the treatment of acute variceal bleeding. However, the risks and benefits of these interventions are not well understood.<\/jats:p>\n <\/jats:sec>\n \n Aim<\/jats:title>\n To undertake a meta\u2010analysis of the efficacy of vasoactive medications in patients having acute variceal bleeds.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n Randomised controlled trials (\n RCTs<\/jats:styled-content>\n ) of vasopressin, somatostatin and their analogues, administered to patients with acute variceal bleeds were identified based on systematic searches of nine electronic databases and multiple sources of grey literature.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n The search identified 3011 citations, and 30 trials with a total of 3111 patients met eligibility criteria. The use of vasoactive agents was associated with a significantly lower risk of 7\u2010day mortality (\n RR<\/jats:styled-content>\n 0.74; 95%\n CI<\/jats:styled-content>\n 0.57\u20130.95;\n P\u00a0<\/jats:italic>\n =\n \u00a0<\/jats:italic>\n 0.02;\n I<\/jats:italic>\n 2<\/jats:sup>\n \u00a0=\u00a00%; moderate quality of evidence), and a significant improvement in haemostasis (\n RR<\/jats:styled-content>\n 1.21, 95%\n CI<\/jats:styled-content>\n 1.13\u20131.30;\n P<\/jats:italic>\n \u00a0<\u00a00.001;\n I<\/jats:italic>\n 2<\/jats:sup>\n \u00a0<\/jats:italic>\n =\n \u00a0<\/jats:italic>\n 28%; very low quality of evidence), lower transfusion requirements (pooled mean difference \u22120.70 units of blood transfused, 95%\n CI<\/jats:styled-content>\n \u22121.01 to \u22120.38;\n P<\/jats:italic>\n \u00a0<\u00a00.001;\n I<\/jats:italic>\n 2<\/jats:sup>\n \u00a0<\/jats:italic>\n =\n \u00a0<\/jats:italic>\n 82%; moderate quality of evidence), and a shorter duration of hospitalisation (pooled mean difference \u22120.71\u00a0days; 95%\n CI<\/jats:styled-content>\n \u22121.23 to \u22120.19;\n P\u00a0<\/jats:italic>\n =\n \u00a0<\/jats:italic>\n 0.007;\n I<\/jats:italic>\n 2<\/jats:sup>\n \u00a0<\/jats:italic>\n =\n \u00a0<\/jats:italic>\n 0%; low quality of evidence). Studies comparing different vasoactive agents did not show a difference in efficacy, although the quality of evidence was very low.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n The use of vasoactive agents was associated with a significantly lower risk of acute all\u2010cause mortality and transfusion requirements, and improved control of bleeding and shorter hospital stay. Studies comparing different vasoactive medications failed to demonstrate a difference in efficacy.<\/jats:p>\n <\/jats:sec>","DOI":"10.1111\/j.1365-2036.2012.05088.x","type":"journal-article","created":{"date-parts":[[2012,4,8]],"date-time":"2012-04-08T20:54:34Z","timestamp":1333918474000},"page":"1267-1278","source":"Crossref","is-referenced-by-count":203,"title":["Meta\u2010analysis: vasoactive medications for the management of acute variceal bleeds"],"prefix":"10.1111","volume":"35","author":[{"given":"M.","family":"Wells","sequence":"first","affiliation":[{"name":"Schulich School of Medicine and Dentistry University of Western Ontario London ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Chande","sequence":"additional","affiliation":[{"name":"Schulich School of Medicine and Dentistry University of Western Ontario London ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Adams","sequence":"additional","affiliation":[{"name":"Schulich School of Medicine and Dentistry University of Western Ontario London ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Beaton","sequence":"additional","affiliation":[{"name":"Schulich School of Medicine and Dentistry University of Western Ontario London ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Levstik","sequence":"additional","affiliation":[{"name":"Schulich School of Medicine and Dentistry University of Western Ontario London ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Boyce","sequence":"additional","affiliation":[{"name":"Schulich School of Medicine and Dentistry University of Western Ontario London ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mrkobrada","sequence":"additional","affiliation":[{"name":"Schulich School of Medicine and Dentistry University of Western Ontario London ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,4,8]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20339"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07294.x"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50385"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(81)90144-X"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.t01-1-07705.x"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1159\/000051417"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.22451"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1007133"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01481.x"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21907"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.06.004"},{"key":"e_1_2_8_13_1","volume-title":"Complications in the medical treatment of portal hypertension. Portal Hypertension III","author":"Bolognesi M BG","year":"2001"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840020602"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.20.7.565"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510310304"},{"key":"e_1_2_8_17_1","first-page":"489","article-title":"Octreotide reduces azygos blood flow in cirrhotic patients with portal hypertension","volume":"2","author":"McCormick PA DR","year":"1990","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"e_1_2_8_18_1","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","year":"2011"},{"key":"e_1_2_8_19_1","first-page":"CD002233","article-title":"Emergency sclerotherapy versus vasoactive drugs for bleeding oesophageal varices in cirrhotic patients","volume":"17","author":"D'Amico G","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(03)00269-5"},{"key":"e_1_2_8_21_1","first-page":"CD000193","article-title":"Somatostatin analogues for acute bleeding oesophageal varices","volume":"16","author":"Gotzsche PC","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_22_1","first-page":"CD002147","article-title":"Terlipressin for acute esophageal variceal hemorrhage","volume":"1","author":"Ioannou G","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_23_1","first-page":"CD002147","article-title":"Terlipressin for acute esophageal variceal hemorrhage","volume":"1","author":"Ioannou G","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39489.470347.AD"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)05099-X"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199508313330904"},{"key":"e_1_2_8_27_1","first-page":"207A","article-title":"Sclerotherapy alone vs scherotherapy plus terlipressin vs sclerotherapy plus octreotide in the treatment of acute variceal hemorrhage","volume":"24","author":"Brunati X CR","year":"1996","journal-title":"Hepatology"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(90)91166-4"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200101043440104"},{"key":"e_1_2_8_30_1","first-page":"539","article-title":"Treatment of bleeding oesophageal varices in cirrhotic patients with pitressin. A controlled study (author's transl)","volume":"41","author":"Clanet J","year":"1978","journal-title":"Acta Gastroenterol Belg"},{"key":"e_1_2_8_31_1","first-page":"S41","article-title":"Sandostatin in the Control of Bleeding Oesophageal Varices: A Randomized Controlled Clinical Trial","volume":"27","author":"El Sayed S","year":"1995","journal-title":"Endoscopy"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-96-5-565"},{"key":"e_1_2_8_33_1","first-page":"283","article-title":"Efficacy of vasopressin in the treatment of gastrointestinal hemorrhage caused by the rupture of esophageal varices. Randomized study: preliminary results","volume":"32","author":"Fourtanier G","year":"1977","journal-title":"Therapie"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-198902000-00014"},{"key":"e_1_2_8_35_1","first-page":"1310","article-title":"Octreotide in acute bleeding esophageal varices: a prospective randomized study","volume":"47","author":"Freitas DS","year":"2000","journal-title":"Hepatogastroenterology"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.310.6993.1495"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92708-5"},{"key":"e_1_2_8_38_1","first-page":"10","article-title":"A clinical study of octreotide in the treatment of bleeding of esophageal and gastric varices","volume":"16","author":"Li SL WM","year":"1996","journal-title":"Chin J Crit Care Med"},{"key":"e_1_2_8_39_1","first-page":"195","article-title":"Octreotide for esophageal variceal bleeding treated with endoscopic sclerotherapy: a randomized, placebo\u2010controlled trial","volume":"54","author":"Morales GF","year":"2007","journal-title":"Hepatogastroenterology"},{"key":"e_1_2_8_40_1","first-page":"407","article-title":"Somatostatin as an adjuvant to emergency sclerotherapy of bleeding esophageal varices","volume":"26","author":"Moret\u00f3 M ZM","year":"1994","journal-title":"Endoscopy"},{"issue":"1","key":"e_1_2_8_41_1","first-page":"55","article-title":"Randomized double blind controlled trial of 5\u00a0day terlipressin vs placebo in acute variceal hemorrhage","volume":"30","author":"Patch D CM","year":"1999","journal-title":"J Hepatology"},{"key":"e_1_2_8_42_1","first-page":"388","article-title":"Terlipressin and somatostatin in the treatment of hemorrhages from rupture of esophageal varices","volume":"18","author":"Pauwels A","year":"1994","journal-title":"Gastroenterol Clin Biol"},{"key":"e_1_2_8_43_1","first-page":"628A","article-title":"Combination of somatostatin plus endoscopic variceal ligation (EVL) is similar to EVL alone in control of acute variceal bleeding: a randomized controlled trial","volume":"48","author":"Sarin SK KA","year":"2008","journal-title":"Hepatology"},{"key":"e_1_2_8_44_1","first-page":"10","article-title":"Sclerotherapy plus octreotide versus sclerotherapy alone in the management of gastro\u2010oesophageal variceal hemorrhage","volume":"17","author":"Shah HA","year":"2005","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"e_1_2_8_45_1","first-page":"109","article-title":"Octreotide infusion plus emergency sclerotherapy versus sclerotherapy alone for the control of bleeding oesophageal varices: a prospective randomized clinical trial","volume":"26","author":"Shiha G HM","year":"1996","journal-title":"Mansoura Med J"},{"key":"e_1_2_8_46_1","first-page":"137A","article-title":"Esophageal varices bleeding: comparison between treatment with sclerotherapy alone versus sclerotherapy plus octreotide","volume":"26","author":"Signorelli S","year":"1997","journal-title":"Hepatology"},{"key":"e_1_2_8_47_1","first-page":"285","article-title":"Octreotide administration and\/or endoscopic treatment in cirrhotic patients with acute variceal bleeding: a multicentric study","volume":"132","author":"Silva G QR","year":"2004","journal-title":"Rev Med Chil"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365529009095539"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(03)80296-9"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92840-5"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840100611"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840060121"},{"key":"e_1_2_8_53_1","first-page":"302","article-title":"Clinical study on octreotide for treatment of bleedeing of esophageal varices","volume":"13","author":"Xu YC WG","year":"1993","journal-title":"Chin J Digestion"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.01858.x"},{"key":"e_1_2_8_55_1","first-page":"692","article-title":"Terlipressin (glypressin) versus somatostatin in the treatment of bleeding esophageal varices\u2013final report of a placebo\u2010controlled, double\u2010blind study","volume":"34","author":"Walker S","year":"1996","journal-title":"Z Gastroenterol"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(82)91689-0"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(05)80059-5"},{"key":"e_1_2_8_58_1","first-page":"1091","article-title":"Upper digestive hemorrhage. Comparison of terlipressin and octreotide","volume":"48","author":"Campisi C","year":"1993","journal-title":"Minerva Chir"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1990.tb01439.x"},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.290.6464.275"},{"key":"e_1_2_8_61_1","first-page":"373","article-title":"A prospective study comparing the efficacy of early administration of terlipressin and somatostatin for the control of acute variceal bleeding in patients with cirrhosis","volume":"12","author":"Seo YS","year":"2006","journal-title":"Korean J Hepatol"},{"key":"e_1_2_8_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(05)80663-4"},{"key":"e_1_2_8_63_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03539.x"},{"key":"e_1_2_8_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840040315"},{"key":"e_1_2_8_65_1","first-page":"385","article-title":"Comparison of terlipressin and octreotide with variceal ligation for controlling acute esophageal variceal bleeding\u2013a randomized prospective study","volume":"12","author":"Cho SB","year":"2006","journal-title":"Korean J Hepatol"},{"key":"e_1_2_8_66_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v111.pm8898643"},{"key":"e_1_2_8_67_1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1742-1241.2002.tb11295.x","article-title":"Effects of somatostatin, octreotide and pitressin plus nitroglycerine on systemic and portal haemodynamics in the control of acute variceal bleeding","volume":"56","author":"Zhang HB","year":"2002","journal-title":"Int J Clin Pract"},{"key":"e_1_2_8_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00212982"},{"key":"e_1_2_8_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2008.147"},{"key":"e_1_2_8_70_1","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2003.18.3.161"},{"key":"e_1_2_8_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(01)81145-4"},{"key":"e_1_2_8_72_1","first-page":"95","article-title":"Comparison of terlipressin plus sclerotherapy with somatostatin plus sclerotherapy to control bleeding from esophageal varices in with Child C cirrhosis patients","volume":"12","author":"Ali H AY","year":"2001","journal-title":"Turkish Journal of Gastroenterology."},{"key":"e_1_2_8_73_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840180111"},{"key":"e_1_2_8_74_1","first-page":"155","volume-title":"Vasopressin Analogs and Portal Hypertension","author":"Desaint B","year":"1987"},{"key":"e_1_2_8_75_1","first-page":"131","article-title":"A randomized controlled study of triglycyl\u2010vasopressin and vasopressin plus nitrglycerin in the control of acute esophageal variceal hemorrhage","volume":"5","author":"Lee YF TY","year":"1988","journal-title":"Chinese J Gastroenterol"},{"key":"e_1_2_8_76_1","first-page":"21","article-title":"Effect of somatostatin in controlling bleeding from esophageal varices","volume":"17","author":"Bagarani M AV","year":"1987","journal-title":"Italian Journal of Surgical Sciences."},{"key":"e_1_2_8_77_1","first-page":"804","article-title":"Comparison of somatostatin and vasopressin in bleeding esophageal varices","volume":"85","author":"Saari A KE","year":"1990","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_8_78_1","first-page":"459A","article-title":"Comparative Study of Terlipressin, Somatostatin, and Octreotide in Acute Esophageal Variceal Bleed: A Prospective Randomised Study","volume":"54","author":"Ck A","year":"2011","journal-title":"Hepatology"},{"key":"e_1_2_8_79_1","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1980.01380010022004"},{"key":"e_1_2_8_80_1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0016-5085(75)80001-1","article-title":"Intraarterial vasopressin in the treatment of upper gastrointestinal hemorrhage: a prospective, controlled clinical trial","volume":"68","author":"Conn HO","year":"1975","journal-title":"Gastroenterology"}],"container-title":["Alimentary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2012.05088.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2012.05088.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T01:00:15Z","timestamp":1700528415000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2012.05088.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,8]]},"references-count":79,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["10.1111\/j.1365-2036.2012.05088.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2012.05088.x","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.722676537.793561263","asserted-by":"object"}]},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,8]]}}}